MELK is a potential therapeutic target for cervical cancer and its high expression is associated with poor prognosis in adrenocortical carcinoma (Kiseljak-Vassiliades et al., 2018; Wang et al., 2018). This evidence concerns the gene MELK and adrenal cortex carcinoma.